Peter J. McLaughlin, Ph.D. - Publications

Affiliations: 
1997-2001 Psychology Stony Brook University, Stony Brook, NY, United States 
 2001-2006 Psychology University of Connecticut, Storrs, CT, United States 
 2006- Psychology Edinboro University of PA 

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Nicklas PR, Kiefer ML, Whalen MA, Stewart MT, Mosura DE, Bennett EM, Hawley WR, McLaughlin PJ. Muscarinic M1, but not M4, receptor antagonism impairs divided attention in male rats. Pharmacology, Biochemistry, and Behavior. 205: 173184. PMID 33836220 DOI: 10.1016/j.pbb.2021.173184  0.317
2017 McLaughlin PJ, Jagielo-Miller JE, Plyler ES, Schutte KK, Vemuri VK, Makriyannis A. Differential effects of cannabinoid CB1 inverse agonists and antagonists on impulsivity in male Sprague Dawley rats: identification of a possibly clinically relevant vulnerability involving the serotonin 5HT1A receptor. Psychopharmacology. PMID 28144708 DOI: 10.1007/S00213-017-4548-2  0.327
2016 Thompson EE, Jagielo-Miller JE, Vemuri VK, Makriyannis A, McLaughlin PJ. CB1 antagonism produces behaviors more consistent with satiety than reduced reward value in food-maintained responding in rats. Journal of Psychopharmacology (Oxford, England). PMID 27005309 DOI: 10.1177/0269881116639287  0.413
2013 Miller RL, Thakur GA, Stewart WN, Bow JP, Bajaj S, Makriyannis A, McLaughlin PJ. Effects of a novel CB1 agonist on visual attention in male rats: role of strategy and expectancy in task accuracy. Experimental and Clinical Psychopharmacology. 21: 416-25. PMID 24099361 DOI: 10.1037/A0033668  0.383
2013 McLaughlin PJ, Thakur GA, Vemuri VK, McClure ED, Brown CM, Winston KM, Wood JT, Makriyannis A, Salamone JD. Behavioral effects of the novel potent cannabinoid CB1 agonist AM 4054. Pharmacology, Biochemistry, and Behavior. 109: 16-22. PMID 23603029 DOI: 10.1016/J.Pbb.2013.04.011  0.696
2010 McLaughlin PJ, Winston KM, Swezey LA, Vemuri VK, Makriyannis A, Salamone JD. Detailed analysis of food-reinforced operant lever pressing distinguishes effects of a cannabinoid CB1 inverse agonist and dopamine D1 and D2 antagonists. Pharmacology, Biochemistry, and Behavior. 96: 75-81. PMID 20403373 DOI: 10.1016/J.Pbb.2010.04.009  0.662
2008 Hodge J, Bow JP, Plyler KS, Vemuri VK, Wisniecki A, Salamone JD, Makriyannis A, McLaughlin PJ. The cannabinoid CB1 receptor inverse agonist AM 251 and antagonist AM 4113 produce similar effects on the behavioral satiety sequence in rats. Behavioural Brain Research. 193: 298-305. PMID 18602425 DOI: 10.1016/J.Bbr.2008.06.010  0.805
2008 McLaughlin PJ, Chuck TL, Arizzi-LaFrance MN, Salamone JD, Correa M. Central vs. peripheral administration of ethanol, acetaldehyde and acetate in rats: effects on lever pressing and response initiation. Pharmacology, Biochemistry, and Behavior. 89: 304-13. PMID 18294679 DOI: 10.1016/J.Pbb.2008.01.002  0.723
2008 Mingote S, Pereira M, Farrar AM, McLaughlin PJ, Salamone JD. Systemic administration of the adenosine A(2A) agonist CGS 21680 induces sedation at doses that suppress lever pressing and food intake. Pharmacology, Biochemistry, and Behavior. 89: 345-51. PMID 18281083 DOI: 10.1016/J.Pbb.2008.01.006  0.79
2008 Sink KS, McLaughlin PJ, Wood JA, Brown C, Fan P, Vemuri VK, Peng Y, Pang Y, Olszewska T, Olzewska T, Thakur GA, Makriyannis A, Parker LA, Salamone JD. The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 946-55. PMID 17581535 DOI: 10.1038/Sj.Npp.1301476  0.711
2008 Sink KS, McLaughlin PJ, Wood JAT, Brown C, Fan P, Vemuri VK, Pang Y, Olzewska T, Thakur GA, Makriyannis A, Parker LA, Salamone JD. The novel cannabinoid CB1 receptor neutral antagonist Am4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats (Neuropsychopharmacology (2008) 33, (946-955) DOI: 10.1038/sj.npp.1301476) Neuropsychopharmacology. 33: 1776. DOI: 10.1038/npp.2008.49  0.653
2007 Betz AJ, McLaughlin PJ, Burgos M, Weber SM, Salamone JD. The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors. Psychopharmacology. 194: 347-59. PMID 17594079 DOI: 10.1007/S00213-007-0844-6  0.768
2007 Salamone JD, McLaughlin PJ, Sink K, Makriyannis A, Parker LA. Cannabinoid CB1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions. Physiology & Behavior. 91: 383-8. PMID 17521686 DOI: 10.1016/J.Physbeh.2007.04.013  0.697
2006 McLaughlin PJ, Qian L, Wood JT, Wisniecki A, Winston KM, Swezey LA, Ishiwari K, Betz AJ, Pandarinathan L, Xu W, Makriyannis A, Salamone JD. Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist/inverse agonist AM 1387. Pharmacology, Biochemistry, and Behavior. 83: 396-402. PMID 16616951 DOI: 10.1016/J.Pbb.2006.02.022  0.743
2006 Chuck TL, McLaughlin PJ, Arizzi-LaFrance MN, Salamone JD, Correa M. Comparison between multiple behavioral effects of peripheral ethanol administration in rats: sedation, ataxia, and bradykinesia. Life Sciences. 79: 154-61. PMID 16487981 DOI: 10.1016/J.Lfs.2005.12.045  0.733
2006 Brown C, Salamone JD, Sink K, McLaughlin PJ. WITHDRAWN: Effects of cannabinoid antagonists on intake of different foods Appetite. DOI: 10.1016/J.Appet.2006.03.285  0.618
2005 McLaughlin PJ, Brown CM, Winston KM, Thakur G, Lu D, Makriyannis A, Salamone JD. The novel cannabinoid agonist AM 411 produces a biphasic effect on accuracy in a visual target detection task in rats. Behavioural Pharmacology. 16: 477-86. PMID 16148454 DOI: 10.1097/00008877-200509000-00022  0.552
2005 McLaughlin PJ, Winston KM, Limebeer CL, Parker LA, Makriyannis A, Salamone JD. The cannabinoid CB1 antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats. Psychopharmacology. 180: 286-93. PMID 15948012 DOI: 10.1007/S00213-005-2171-0  0.681
2005 McLaughlin PJ, Lu D, Winston KM, Thakur G, Swezey LA, Makriyannis A, Salamone JD. Behavioral effects of the novel cannabinoid full agonist AM 411. Pharmacology, Biochemistry, and Behavior. 81: 78-88. PMID 15894067 DOI: 10.1016/J.Pbb.2005.02.005  0.664
2005 Salamone J, Betz A, McLaughlin P, Burgos M, Ishiwari K, Weber S, Felsted J, Brown C. B15 AN ANIMAL MODEL FOR ASSESSING THE POTENTIAL ANTIPARKINSONIAN CHARACTERISTICS OF M4 MUSCARINIC ANTAGONISTS: EFFECTS OF THE PARTIALLY SELECTIVE M4 ANTAGONIST TROPICAMIDE Behavioural Pharmacology. 16: S70. DOI: 10.1097/00008877-200509001-00220  0.737
2003 McLaughlin PJ, Winston K, Swezey L, Wisniecki A, Aberman J, Tardif DJ, Betz AJ, Ishiwari K, Makriyannis A, Salamone JD. The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats. Behavioural Pharmacology. 14: 583-8. PMID 14665975 DOI: 10.1097/00008877-200312000-00002  0.749
2002 McLaughlin PJ, Robinson JK. Galanin: Involvement in Behavior and Neuropathology, and Therapeutic Potential. Drug News & Perspectives. 15: 647-653. PMID 12677250 DOI: 10.1358/Dnp.2002.15.10.840020  0.458
2001 Kritzer MF, McLaughlin PJ, Smirlis T, Robinson JK. Gonadectomy impairs T-maze acquisition in adult male rats. Hormones and Behavior. 39: 167-74. PMID 11243744 DOI: 10.1006/Hbeh.2001.1645  0.467
2000 Mclaughlin PJ, Delevan CE, Carnicom S, Robinson JK, Brener J. Fine motor control in rats is disrupted by delta-9-tetrahydrocannabinol. Pharmacology, Biochemistry, and Behavior. 66: 803-9. PMID 10973519 DOI: 10.1016/S0091-3057(00)00281-1  0.484
Show low-probability matches.